戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1                                       In the final 14 days of life, 357 (10%) received chemotherapy.
2 -of-life care, including chemotherapy in the final 14 days of life, intensive care unit (ICU) admissi
3 in hospice, enrollment in hospice during the final 3 days of life, and enrollment in hospice while no
4 invasive or life-extending procedures in the final 30 days of life, enrollment in hospice, enrollment
5 gency room (ER) or hospital admission in the final 30 days of life, invasive or life-extending proced
6 , intensive care unit (ICU) admission in the final 30 days of life, more than one emergency room (ER)
7 e printing method, and the structures of the final 3D-printed products.
8                                To report the final (5-year) results of a prospective study evaluating
9 xclusive use of gadoterate meglumine (plus a final additional nonenhanced MR imaging examination) wer
10 clinical and endoscopic remission), with the final aim of blocking their progression and preventing b
11                                     With the final aim of testing the therapeutic efficacy of UCB in
12 vated concentration of BP-3 for 32 days; the final air concentration was 4.4 mug/m(3).
13 ng from FPP to GPP, until replacement of the final alpha-helix, whereupon cyclopropanation and branch
14 ng functional MRI in 28 healthy adults, with final analyses based on 20 individuals following extensi
15                                       At the final analysis (Aug 1, 2016), 31 patients had had a prog
16                     Of the 2654 women in the final analysis (mean [SD] age, 31.0 [5.7] years), most w
17 dable MRI), leaving a sample size of 243 for final analysis (mean [SD] age, 72.8 [9.1] years; 116 men
18                                          The final analysis cohort included 88 eyes in 3 groups: mont
19                                  This is the final analysis from GATSBY, a randomised, open-label, ad
20                                          The final analysis included 4131 patients (2661 in the boost
21    Survival was assessed every 12 weeks, and final analysis occurred after all patients were followed
22 d 227 participants, with 205 included in the final analysis of the primary outcome.
23                               The cutoff for final analysis was 450 patients with 346 deaths.
24                              The date of the final analysis was October 20, 2016.
25                                       In the final analysis, a significantly higher percentage of inf
26                               We present the final analysis, although at the time of the database loc
27 6-83 years]) with 23 lesions included in the final analysis, the mean (SD) surgical defect area estim
28 ied inclusion criteria, were included in the final analysis.
29  patients enrolled, 730 were included in the final analysis.
30 nd point and the secondary end points in the final analysis.
31 ed after 1 year and this report presents the final analysis.
32 bo follow-up period, but was included in the final analysis.
33 res, 126 in each group, were included in the final analysis.
34 ups of children could not be included in the final analysis: 147 migrated out of the study area (67 i
35                                       Of the final analytic sample of 9512 enlisted soldiers who atte
36  whom surgery type was known constituted the final analytic sample.
37 al revealed that time from groin puncture to final angiographic result was shorter with patients unde
38  of raw data sequencing into a comprehensive final annotated report of predicted superenhancers.
39                                        Thus, final application of the developed methodology to the co
40 ure also highlights a loss of focus from the final application.
41 ing of chlorophyll f at 740 nm, we observe a final approximately 150 ps decay assigned to trapping by
42 highly strained 1,2-trans ring fusion of the final architecture.
43 eleased during fermentation to influence the final aroma of wine.
44      After histology reports were available, final assessments of usability were made.
45  a foundation for future improvements in the final beer-making process.
46 fference between the median preoperative and final best-corrected visual acuity (BCVA) was assessed a
47                               Uric acid is a final breakdown product of purine catabolism in humans.
48                                              Final case adjudication was based on conclusive diagnost
49  morphology in high throughput, but only the final cell counts are commonly used for clinical decisio
50 thylation status, and their correlation with final challenge symptom scores were determined.
51 ter in raw fresh cocoa beans to 4mg/g in the final chocolate product.
52  6mg epicatechin equivalents per gram in the final chocolate.
53  give more weight to inlying elements in the final choice ("robust averaging").
54 t a flat model that directly selects between final choices accounts more parsimoniously for the repor
55  was incidence of hearing loss 4 weeks after final cisplatin dose.
56 the 874 individuals ever diagnosed with MCI, final clinical diagnoses were varied: 39.2% died with an
57                                              Final clinical sensitivity values of the Aries Flu A/B &
58 Alternative splicing (AS) that occurs at the final coding exon (exon 47) of the Cav2.1 voltage-gated
59 ad an identifiable matching control subject (final cohort, 11 patients and 11 control subjects).
60                                The yield and final color quality of spray dried PCC anthocyanins were
61 d allosteric stimulation of FVIIa provided a final complex with FVIIa-like activity in solution, whil
62 ad been collected in acetic acid (0.5%; mean final concentration).
63 ited for samples that contain metabolites at final concentrations between 1 nM and 10 muM, and they a
64 ures through neural network learning for the final contact map prediction.
65                                              Final content of reducing sugars, ethanol, acetic acid,
66 s postulated by us as an intermediate to the final conversion to carboxylic acids.
67 centers between July 2011 and June 2016; the final date of follow-up was June 29, 2016.
68 nties (June 24, 2009, to August 26, 2015-the final date of follow-up).
69 ction mechanism, reaction intermediates, and final degradation products were analyzed by UV/vis, NMR,
70 ining process and remain unaltered after the final deodorizing step.
71                                              Final diagnoses were based on local and central results.
72                                              Final diagnoses were established by histopathologic exam
73 inations as regards the suspected causes and final diagnoses.
74  over the same period who had an alternative final diagnosis (CJD mimics).
75 en than in men in terms of time to reach the final diagnosis and downstream testing.
76 malignancy, there was a significant delay to final diagnosis in the CT group compared with the (18)F-
77 to an appropriate differential diagnosis and final diagnosis is highlighted in our case report.
78                                          The final diagnosis of AMI was independently adjudicated usi
79                          From 355 cases with final diagnosis of PTB, 263 (71.8%) had definite diagnos
80                                          The final diagnosis was adjudicated by 2 independent cardiol
81                                          The final diagnosis was adjudicated in patients presenting w
82                                          The final diagnosis was established based on selective angio
83                    All images led to a clear final diagnosis.
84 f the detachment process but also modify the final distribution of the bacteria on the surface.
85 seline, FUV1, FUV2 and at a FUV 1 year after final dose (FUV3; 2014 Cohort only).
86 ve levels, with 2 days at each dose, and the final dose achieved on day 9.
87 ard of care, every 4 weeks for 24 weeks (the final dose was given at week 20).
88 dose of study treatment to 30 days after the final dose).
89                            14 days after the final dose, the groups were each crossed over to the oth
90 e mice extended beyond 70 days following the final dose.
91 w-up visit [FUV] 1) and 3 (FUV2) weeks after final dose.
92 drinking water treatment processes shape the final drinking water microbial community via selection o
93 ed are the synthetic studies that led to the final eight-step synthesis of dehaloperophoramidine.
94 ead movements, abducens motoneurons form the final element of the reflex arc that integrates visuoves
95 tsky Rise was remarkably emergent during its final emplacement phase.
96  Practice Guidelines Committee, approved the final endorsement.
97                    Besides satisfying annual final energy demand, the model constraints comprise avai
98          Expression of the gene encoding the final enzymatic step in solanapyrone biosynthesis was sp
99 ve propensities for each to propagate to the final folded native state.
100 ly (18.1 vs. 18.7 mm, P < 0.0001) and at the final follow-up (21.4 vs. 22.1 mm, P = 0.0004).
101 m August 1, 2010, through December 31, 2011; final follow-up assessment was in April 2014.
102 een January 1, 2001, and June 30, 2014, with final follow-up date December 31, 2014.
103                                          The final follow-up date was December 31, 2014.
104 o-controlled, randomized trial (July 2013 to final follow-up October 2014) conducted in 54 family pra
105 ary 1, 2012, through December 31, 2016, with final follow-up on December 31, 2016.
106                                          The final follow-up visit was on August 15, 2017.
107                                              Final follow-up was August 2012.
108                                              Final follow-up was completed on May 9, 2016.
109 p was conducted at 30 days and 6 months, and final follow-up was on June 16, 2015.
110 ecreased significantly to 318 +/- 159 mum at final follow-up, AG (p < 0.0001).
111 up and improved slightly to 0.53 +/- 0.71 at final follow-up, AG (p = 0.46).
112 ptember 2016), with a follow-up of 6 months (final follow-up, March 28, 2017).
113 up and improved slightly to 0.60 +/- 0.36 at final follow-up, RG (p = 0.64).
114  between January 1, 2007, and June 30, 2013 (final follow-up: December 31, 2013), were assessed.
115 h the same amount of added calcium salt, the final G' of milk gel followed the same order.
116                                          The final genetic map contains 7,192 successfully mapped mar
117 Solanaceae were well diversified long before final Gondwanan breakup.
118 ce included recommendation statements in the final guideline only if they reached an 80% acceptance t
119  between children with peak growth at 90% of final height and skeletal maturity closely reflecting gr
120                   This ability to use 90% of final height as easily identified important maturity sta
121 which reported growth as change in height or final height were included.
122                                          The final HILIC/ESI-MS/MS method is applied for the analysis
123 cs with severe NMR line broadening until the final hydrogen bonds are formed.
124 = 101), and one 3-6 mo later to document the final implemented management (Q3; n = 56).
125 ngth >/=24 mm, deferred stenting reduced the final infarct size (6% LV; IQR: 2% to 18% vs. 13% LV; IQ
126                     The primary endpoint was final infarct size.
127  splenic tissues were harvested 7 days after final injection and subjected to inductively coupled pla
128 aging was used as the reference standard for final IS and viability assessment.
129  demonstrated the best linear correlation to final IS at a threshold of >46% (R=0.96; 95% CI, 0.92-0.
130 rior to acute LGE in terms of agreement with final IS.
131                                            A final lactulose concentration of 6.7+/-0.4g/L was determ
132 silencing phase that largely determine their final life spans.
133                                              Final losses of up to 74, 45 and 78% were found for AA,
134                  We identified predictors of final macular status, and developed two predictive model
135                                          The final management decision should be individualized for s
136 1, Rio2 and Pno1 collectively preclude their final maturation, thereby preventing untimely tRNA and m
137                                          The final model demonstrated good performance for both RVAD
138                                            A final model evaluation was conducted based on representa
139      A multiple-regression analysis led to a final model explaining FLI best through BMI, waist circu
140                                          The final model identified a mean (95% confidence interval)
141 g to the prognostic index developed from the final model.
142                                          The final models with R(2) values ranging from 0.64 for p-xy
143 ycaemic control (single-blind placebo in the final month).
144 pace that converges separately onto the same final motor neuron state as the standard path.
145 ation stroke treated with MT and achieving a final mTICI score 2b or 3.
146  maintained significance of P </= .15 in the final multivariable models.
147  with a large variety of amines provided the final N-acylguanidines, with the overall formation of on
148 tic transformation mechanism that leads to a final nanolaminate structure of alpha'' (orthorhombic) m
149  excluded from further analysis because of a final noninfectious etiology or lack of further follow-u
150 et al risk model, and the C statistic of the final noninvasive risk model was determined using bootst
151 time without compromising the quality of the final NPs.
152 pears to have a very significant role on the final number of simulated double strand breaks.
153 1) and from baseline state (VISUAL-2) to the final or early termination visit was determined in each
154 rotation that brings them on-axis with their final orientation.
155                                              Final OS among patients not receiving previous pelvic ra
156 e to begin any of these inductions while the final outcome depends on the tissue emitting the later s
157                                  Eyes with a final outcome of NLP were further reviewed to determine
158                          Nineteen eyes had a final outcome of NLP, representing 16.0%.
159 iented sister kinetochores, representing the final outer kinetochore component recruited prior to ana
160 ty of peaks is of pivotal importance for the final output of the proposed method, we provide a compre
161                   We report results from the final overall survival analysis of the TH3RESA trial.
162  then becoming a nucleophilic oxidant in the final oxidation of an aryl-nitroso intermediate to the a
163 ound to occur at ambient temperature and the final oxidative cyclization occurs when the substrate is
164                               The third- and-final part proposes ideas for further improvement in blu
165 e ARP2/3 complex signaling pathway, a common final pathway for multiple signaling cascades that regul
166                                          The final patient developed vomiting and diarrhea, started p
167 tations, the algorithm displays an excellent final performance, with an area under the curve (AUC) of
168                                            A final PET quantitative stability assessment for simultan
169 g the time interval between RO treatment and final pH adjustment can significantly reduce NDMA re-for
170 , and ketones characterized the aroma of the final pineapple vinegar, whilst off-flavors were signifi
171  main stem branching, rosette branching, and final plant height and observed several strong positive
172      Neither TMBPF nor the migrants from the final polymeric coating increased proliferation of estro
173 e geometry and materials architecture of the final porous fibers.
174  higher after POT+SB dilation or SB stenting+final POT versus after MV stenting and POT.
175 ed to >0.75 after SB dilation or SB stenting+final POT.
176 estimated association rates and improved our final prediction by using a cross-validation test.
177                                          The final prediction model included age (A), biomarkers (B)
178 1), 1711.8mgkg(-1) and 2959.2mgkg(-1) in the final product (T0), and after 1 (T1) and 3 (T3) months o
179 olase located in family GH105, producing the final product 4-deoxy-beta-l-threo-hex-4-enepyranosyl-ur
180 nt purification strategies to obtain a clean final product and thus avoid ambiguities in the source o
181 a soluble intermediate and then an insoluble final product magnesium iodide.
182  pathway, without substantially changing the final product of aggregation.
183 s(III) and methylarsenite (MAs[III]), with a final product of dimethylarsenate (DMAs[V]).
184  assays and plant extracts indicate that the final product of the ALD1-catalyzed reaction is enaminic
185                                  Even if the final product of the exchange, in both cases, was rock-s
186 ructure characterization typically image the final product or laboriously determine the presence of i
187 vironmentally friendly methodologies and the final product presented acceptable sensory characteristi
188  This enrichment exhibited the largest NH2OH:final product ratio (1.92%), followed by N. multiformis
189           The consumer acceptance (n=200) of final product showed the sensory scores in the range of
190 truct to a CAR-signalling tail and named the final product TCR-CAR.
191   Since the salt represents around 4% of the final product, it will therefore strongly influence the
192             Cyclooxygenases (COXs) and their final product, prostaglandin E2 (PGE2), are known to pla
193 operties, applications, economy, etc. of the final product.
194 lite cultivars with specific end-uses of the final product.
195 scovering materials or understanding how the final products form.
196 product distribution covers about 90% of the final products, and we are able to discriminate between
197                                       As for final products, the highest T-2/HT-2 concentrations were
198 rtant roles for minimizing mycotoxins in the final products, while the recipe formulation has an impa
199  intermediates along the reaction pathway to final products.
200 e the precursors of the mono- and bis-adduct final products.
201 e efficient to remove the urethanes from the final products.
202       Degree of hard tissue loss and type of final prosthetic restoration should be carefully conside
203 ions in the sample and greatly enhancing the final QDS rate in the finite-size scenario.
204 g 974 in the baseline quarter and 972 in the final quarter who met inclusion criteria.
205 the cell; 2) Long processing time before the final readout makes it difficult to capture transient si
206                   An all-or-none step led to final release of ESCRT-III and Vps4.
207 e reactors though was due to starvation, and final removal rates did not differ between reactors inoc
208                                  This is the final report of the first case-control study evaluating
209                                          The final result should be a generalizable model that takes
210 onal radiology played a decisive role in the final result.
211        This trial has been completed and the final results are reported.
212         The trial has been completed and the final results are reported.
213                                          The final results of the PREVAIL trial, both alone and as pa
214                        Purpose To report the final results on treatment outcomes of a randomized tria
215               The antioxidant activity had a final retention of 38.5-59.5%.
216                                          The final risk adjustment model included procedure-type risk
217                                          The final risk score included the following predictors: havi
218 lues were assigned to predictive factors and final risk score is correlated with the percent risk of
219           After progression, patients made a final rotation to either pazopanib or everolimus monothe
220 chronously through schizogony, with only the final round of DNA replication and segregation being syn
221 rea reproducibility approximately 2-fold, to final RSD values of 2.2-4.7% (n = 900).
222                                     For word-final /s, z/ detection, performance was significantly be
223              In summary, Fcomp improved word-final /s, z/ detection.
224                            Results Among the final sample (N = 38,111), risk-adjusted rates of claim
225  schedule as the combination arm) and with a final sample size of 454 patients.
226  identified, 24 studies were included in the final sample.
227                 In VISUAL-1, the change from final score to best score in NEI VFQ-25 was -1.30 for ad
228       Secondary outcomes included initial vs final scores by country, scores among surgeons trained b
229                                            A final section draws attention to the significance and ap
230 iction interval from the presentation of the final sentence item.
231 gle dendrites and somata of L5 neurons', the final sentence of the second paragraph incorrectly cited
232                          The accuracy of the final Sequence-Specific Retention Calculator (SSRCalc) S
233                              Purc infers the final sequences from the raw reads via an iterative appr
234 e comparison method, the correlations of the final SFFQ were similar with 7DDRs (mean r = 0.63) and A
235 hose individual growth rates differ, yet the final shape of organs is highly robust.
236 s with a focus on the rational design of the final shapes.
237 2@Au92@Au54, which is further protected by a final shell of Au48.
238                                          The final SMH values were compared to the starting values (a
239 ness (SMH) using Knoop microhardness tester (final SMH), and roughness and 2D profiles using atomic f
240 d to further refine the model and choose the final sparse SNPs.
241 automatically tracked spindles indicate that final spindle position is determined largely by cell mor
242 unseled that the Fontan is typically not the final stage of single-ventricle palliation.
243 as a compact conformer is favored during the final stages of dehydration.
244  of the spatial and temporal dynamics of the final stages of embolism removal.
245 PY detects aggregation of peroxisomes during final stages of programmed cell death and can be used as
246 nterprotamine sulfur-sulfur bonds during the final stages of sperm maturation.
247 e of events coordinating K(+) uptake and the final stages of vesicle traffic.
248                         First, anemia is the final state in iron depletion.
249 can Society for Human Genetics, endorsed the final statement.
250 onstrate how this can lead to a new class of final states different from those possible with dissipat
251 ced by 10 and 13 electrons, respectively, to final states with all bridging ligands doubly reduced an
252 cycle adopts a boat-like conformation at the final station, which contrasts with the chair-like confo
253  strontium isotope ratio is evidenced in the final statistical discrimination of the origin of hams.
254 e and phytyl pyrophosphate, required for the final step in chlorophyll a synthesis.
255  (now known as SELENOI), responsible for the final step in Kennedy pathway forming phosphatidylethano
256 yl alcohol dehydrogenase (CAD) catalyzes the final step in monolignol biosynthesis, reducing sinapald
257 atic activity of EPT1, thereby hindering the final step in phosphatidylethanolamine synthesis.
258                 Distal sodium transport is a final step in the regulation of blood pressure.
259 6-phosphatase, an enzyme which catalyses the final step of gluconeogenesis and glycogenolysis.
260 , ferrochelatase, the enzyme involved in the final step of heme synthesis, is deficient in these pati
261  of TCA was most effective when added in the final step of the clean-up procedure instead of during e
262 the midhypocotyl, whose expansion drives the final step of this developmental transition under optima
263                                          The final step of this route demonstrates the chemical feasi
264                                       At the final step of VEPART, robustness is assessed by identify
265 ne group that leads to a different series of final steps in one Rh-based catalytic cycle, thereby ena
266                      The slowest step is the final structural maturation of the PRD.
267      Guided by computational studies for the final structure assignment, the stereogenic centers at t
268                                          The final study population included 1,331 EOC cases and 3,01
269                                          The final study population included 176 (18)F-FDG PET/CT stu
270 ion therapy, who underwent MR imaging before final surgery between June 2011 and July 2015.
271   iOCT measurements of interface fluid after final surgical manipulations and immediately before leav
272                                     Rates of final surgical procedure (lumpectomy, unilateral mastect
273 changes in postlumpectomy surgery rates, and final surgical treatment following a 2014 consensus stat
274 source into dust substantially increases the final SVOC concentration in dust in contact with the sou
275 that, should it occur, would lead to a given final systemic loss.
276 nly the first occurrence of any event in the final tally within a conventional time to first event an
277 of dichloramine formed prior to reaching the final target pH.
278                                            A final test demonstrated quantitative stability during a
279  and one workshop, were narrowed down to the final top ten uncertainties of priority for future resea
280 ecursor synthesis pathway, but differ in the final transfer of the TA chain to either peptidoglycan o
281 t preferences; as well as agreement over the final treatment decision.
282 e ice shelf, occurred in 1945 (+/-12 years); final ungrounding of the ice shelf from the ridge occurr
283 ime from liquid precursor continually to the final uniform film.
284 045) were associated with increased risk for final VA <20/200 in the multiple regression model (OR, 4
285 4.41 +/- 6.76 months from presentation, mean final VA was 20/283 (logMAR equivalent of 1.15 +/- 0.15)
286 llomas disappeared within 2 months after the final vaccination.
287                                              Final values of 3.7 and 3.0% were obtained in static and
288 rofound changes during the production of the final virus stock in cell culture.
289 s significantly reduced the growth rates and final virus yields of viruses without inhibiting the exp
290 ile significant decreases in the setback and final viscosities were only detected in oil samples, but
291 eceived intravitreal corticosteroids and had final visual acuities of 20/40, 20/70, and hand movement
292 dings, treatment regimens, culture data, and final visual acuities.
293                             Risk factors for final visual acuity (VA) were analyzed, and rate of stra
294 scularization were important determinants of final visual acuity in eyes with the cuticular drusen ph
295                                 Interval and final visual outcomes (logarithm of the minimum angle of
296  was 20/400 (range 20/60 to hand motion) and final was 20/50 (range 20/30 to 20/400) (P < .05).
297 s the total number of hot flushes during the final week of both treatment periods.
298 lome of roach (Rutilus rutilus) exposed to a final WwTWs effluent for 15 days.
299                                          All final year students were invited to participate.
300 58 (22-167) per person, respectively, by the final years of scale-up.

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top